Abstract
The chromosomal translocation t(8;14)(q24;q32) represents a characteristic marker for Burkitt's lymphoma (BL). This translocation involves the MYC oncogene on chromosome 8 and the immunoglobulin heavy-chain (IgH) locus on chromosome 14. Since the translocation does not produce a fusion gene, we established a long-distance polymerase chain reaction (LD-PCR) assay that can detect the t(8;14) at the genomic level. The sensitivity of the LD-PCR was 10−4. We used the LD-PCR assay to prospectively study 78 BL patients and found a specific PCR product in 52 of them. Among the 52 positive patients, we could test both the tumor and the bone marrow (BM) at diagnosis in 33 and determined the prevalence of minimal disseminated disease (MDD) at diagnosis. In 12/33 patients, BM was positive by LD-PCR and in 10 of them we conducted a study of minimal residual disease (MRD). Eight out of 10 children showed a clearance of MRD after one cycle of chemotherapy. The only two patients who did not achieve a negative MRD status died of disease progression. The comparative analysis of sensitivity of BM aspirate, BM biopsy and LD-PCR in t(8;14)-positive patients demonstrated a superiority of the molecular method in the assessment of MDD. The LD-PCR for t(8;14) is an important tool to study minimal BM infiltration at diagnosis and to determine its response kinetics in BL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shad A, Magrath I . Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG (eds). Principle and Practice of Pediatric Oncology, 3rd edn. Philadelphia: Lippincott-Raven, 1997, pp 545–587.
Dalla Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824–7827.
Pelicci PG, Knowles DMd, Magrath I, Dalla Favera R . Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984–2988.
Basso K, Frascella E, Zanesco L, Rosolen A . Improved long- distance polymerase chain reaction for the detection of t(8; 14)(q24;q32) in Burkitt's lymphomas. Am J Pathol 1999; 155: 1479–1485.
Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, Fukuhara S et al. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal trans-location in mature B-cell neoplasm. Blood 1996; 88: 985–994.
Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification therapy: a report of the Berlin–Frankfurt–Munster group trial NHL-BFM90. Blood 1999; 94: 3294–3306.
Shiramizu B, Magrath I . Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations. Blood 1990; 9: 1848–1852.
Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zulke-Jenisch R et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood 1998; 3: 984–990.
Corradini P, Laddetto M, Pileri A, Tarella C . Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies. Leukemia 1999; 13: 1691–1695.
Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR et al. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (Orange) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer study group report. Leukemia 2002; 16: 594–600.
Csako G, Ian TM, Ronald JE . Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients. Am J Clin Pathol 1982; 78: 712–717.
Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457.
Scimè R, Indovina A, Santoro A, Musso M, Olivieri A, Trincali S et al. PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. Bone Marrow Transplant 1998; 22: 1159–1165.
Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P et al. Eradication of polymerase chain-reaction detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228–2235.
Zutter MM, Hess JL . Guidelines for the diagnosis of leukemia or lymphoma in children. Am J Clin Pathol 1998; 109 (Suppl 1) S9–S22.
Murphy SB, Caces J . Limited utility of bone marrow biopsy in staging children with non-Hodgkin's lymphoma (NHL). Blood 1978; 52 (Suppl 1): 265.
Murphy SB . Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol 1980; 7: 332–339.
Wollner N, Burchenal JH, Lieberman PH, Exelby P, D'Angio G, Murphy ML . Non-Hodgkin's lymphoma in children: a comparative study of two modalities of therapy. Cancer 1976; 37: 123–134.
Haddy TB, Parker RI, Magrath I . Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 1989; 17: 418–423.
Acknowledgements
This work was supported by a grant from ‘Fondazione Città della Speranza’, by MIUR-CNR and by AIL (Associazione Italiana contro le Leucemie). A Lombardi was partially supported by Progetto Ministero della Solute 2001/01/X/000177. We are grateful to Dr S Volpato for statistical analysis and to all the clinicians and pathologists of AIEOP who contributed patients and samples to the study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mussolin, L., Basso, K., Pillon, M. et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 17, 585–589 (2003). https://doi.org/10.1038/sj.leu.2402828
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402828
Keywords
This article is cited by
-
Treatment of Adolescents with Aggressive B-Cell Malignancies: The Pediatric Experience
Current Hematologic Malignancy Reports (2013)
-
IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis
Laboratory Investigation (2009)
-
CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia
Leukemia (2007)
-
Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features
Leukemia (2005)